Creating and distributing additional copies is prohibited without the permission of the publisher. Contact subscriptions@latinfinance.com.

Brazil Pharma Continues Consolidation

Feb 14, 2012

Brazil Pharma continues its consolidation push after agreeing to acquire Sant’ana Drogaria Farmacias in a three-step transaction that values Sant’ana at BRL495.7m ($288.3m). Initially, Brazil Pharma, through its Farmais subsidiary, will acquire a 70% stake in Sant’ana in a BRL347m...

To continue reading please take a free trial, subscribe or login below.


Already have an account?

Subscribe

Subscribe now for unlimited access to all current and archive news, data and market analysis. 

Subscribe

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial

LatinFinance Events



Poll

How much more serious is nationalization risk following YPF and Bolivia's ETE?

View previous results



Printing isn't available for this page.